A patient with features of albright hereditory osteodystrophy and unusual neuropsychiatric findings without coding Gsalpha mutations by Shirin Hasani-Ranjbar et al.
Hasani-Ranjbar et al. Journal of Diabetes & Metabolic Disorders 2014, 13:56
http://www.jdmdonline.com/content/13/1/56CASE REPORT Open AccessA patient with features of albright hereditory
osteodystrophy and unusual neuropsychiatric
findings without coding Gsalpha mutations
Shirin Hasani-Ranjbar1,2,3*, Zahra Jouyandeh2, Mahsa Mohammad Amoli2, Akbar Soltani2
and Seyed Masoud Arzaghi2Abstract
Background: Pseudohypoparathyroidism(PHP) is a heterogeneous group of rare metabolic disorders characterized
by hypocalcemia and hyperphosphatemia resulting from PTH resistance. Different forms of PHP have been reported
based on biochemical and clinical manifestation and genetic findings. Most of these forms are caused by defects in
GNAS, an imprinted gene locus with multiple subunits. We reported a 12- year- old girl with unusual clinical
manifestations of Pseudopseudohypoparathyroidism(PPHP).
Methods: After clinical and biochemical evaluations, the patients’ genomic DNA was isolated from peripheral blood
leukocytes using salting out method. The whole coding sequences of GNAS gene including 13 exons were
amplified by PCR. Quantitative PCR reactions were performed too.
Findings: We described a 12- year- old girl with Albright Hereditory osteodystrophy (AHO) phenotype, poor school
performance, some abnormal movements, TSH resistance with normal serum calcium and phosphorus levels and
normal Gsα bioactivity with no mutation in GNAS exons. Unusual neuropsychiatric findings in this patient were
compatible with Asperger syndrome.
Conclusions: According to our findings this patient could not be categorized in any of PHP subgroups. Identifying of
such individuals may be useful to discover different genetic patterns in pseudohypoparathyroidism and
pseudopseudohypoparathyroidism. It is important to identify patients in whom PHP is caused by novel GNAS mutations,
as careful investigations of these findings will likely further our knowledge of this complex and this unique disorder. In
addition this case presented with unusual neuropsychiatric findings which has not been reported up to now.
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PseudopseudohypoparathyroidismBackground
Pseudohypoparathyroidism(PHP) is a heterogeneous group
of rare metabolic disorders whose common feature is resist-
ance to the parathyroid hormone which results to hypocal-
cemia and hyperphosphatemia [1,2]. Different forms of
PHP are caused by mutations in those exons of GNAS* Correspondence: shirinhasanir@yahoo.com
1Obesity & Eating Habits Research Center, Endocrinology and metabolism
Cellular & Molecular Science Institute, Endocrinology & Metabolism research
institute, Tehran University of Medical Sciences, Tehran, Iran
2Endocrinology and Metabolism Research center, Endocrinology &
Metabolism research institute, Tehran University of Medical Sciences,
Tehran, Iran
Full list of author information is available at the end of the article
© 2014 Hasani-Ranjbar et al.; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumencoding the α subunit [3]. Based on biochemical and clin-
ical manifestation and genetic findings, variable forms of
this disorder have been described.
Heterogeneous mutations located in GNAS exons
which encode Gsα inherited from mother leads to
PHP-Ia in which the characteristic phenotype appear-
ance is Albright’s hereditary osteodystrophy(AHO), in-
cluding obesity, short stature, heterotopis ossification,
brachydactyly and/or mental retardation which has
been described by Albright et al. for the first time in
1942 [4]. This form is also associated with other hor-
monal abnormalities, including hypothyroidism and
hypogonadism [5]. PseudopseudohypoparathyroidismCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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ical features of AHO without any hormonal resistance [6]
caused by heterozygous inactivating mutations in Gsα
coding exons of GNAS which is inherited paternally [7].
In Type-Ib the resistance is restricted only to kidney, with-
out AHO and other hormonal abnormalities. These pa-
tients have maternal microdeletions of STX16 which is
associated with loss of methylation at GNAS exon A/B
[1,3]. Another subtype called I-c is the same as type-Ia
with no difference in clinical phenotype with in some pa-
tients, a mutation that affect the coupling of G protein to
the PTH receptor [8,9]. Patients with PHP Type 2 do not
have the physical appearance of AHO with a normal
cAMP in response to PTH stimulation despite the inher-
ent abnormality in calcium regulation [10,11]. However,
recent reports have provided evidence that overlap can
exist between the clinical features of different PHP sub-
types [12,13]. Different subtypes of pseudohypoparathyr-
oidism are shown in Table 1.
The psychiatric symptoms of pseudohypoparathyroidism
have been reported to be related to Intracerebral calcifica-
tion in basal ganglia [14]. Moderately severe to entirely nor-
mal school performance and moderate degrees of mental
retardation has been reported in patients withPHP-Ia but
not in PHP-Ib [15,16]. Seizure, tetany and laryngeal stridor
may also occur in PHP-Ia because of hypocalcemia [17].
Here we present a case with Albright’s hereditary osteo-
dystrophy phenotype, with normal calcium, phosphate
and PTH levels, in which neurological symptoms, resist-
ance to other hormones and negative GNAS gene muta-
tions were unique findings.
Patients and methods
Mutation analysis of the GNAS gene
The patients’ genomic DNA was isolated from peripheral
blood leukocytes using salting out method. The whole cod-
ing sequences of GNAS gene including 13 exons were amp-
lified by PCR according to the assay described before [18].
Molecular analysis
After collection of heparinized venous blood, lymphocyte
separation was performed using density gradient ficoll
(1.077) and total RNA was extracted using Tripure Isolation
Reagent (Roche Applied Science), according to the manu-
facturer’s protocol. One μg aliquot of total RNA from pa-
tients sample and 3 normal control samples were reverse
transcribed into single-stranded cDNA using randomTable 1 Classification of pseudohypoparathyroidism with AH
PTH resistance Hormone resistance Typ
PHP-Ia Yes Yes
PPHP No No
Case No Yeshexanucleotides primers and expand reverse transcriptase
(Roche Applied Science). cDNA for sample was subjected
to quantitative real-time PCR using the following primers
for HPRT internal quantitative control forward 5′-CC
TGGCGTCGTGATTAGTGAT-3′, reverse 5′- AGACGTT
CAGTCCTGTCCATAA-3′ and GNAS, Forward 5′- TGTA
CAAGCAGTTAATCACCCACCA -3′ and reverse 5′- TCT
GTAGGCCGCCTTAAGCTTTC -3′ primers.
Quantitative PCR
For evaluation of Gs alpha gene quantitative PCR reactions
were performed in 25 ul reaction mixtures containing
250 ng cDNA, 10 ml Takara Real-Time™ SYBR Green/
ROX PCR Master, primer pairs and nuclease-free water to
20 ml. Each biological replicate was run in duplicate on an
ABI Step One quantitative PCR system. Thermocycling
conditions consisted of an initial polymerase activation step
at 95°C for 10 min, followed by 40 cycles at 95°C for 5 s
and 60°C for 30 s. Afterwards, melting curves were gener-
ated to confirm a single gene-specific peak and to detect
primer dimmer formation.Case presentation
Patient
A 12- year- old girl whom parents were distant relatives
was referred to our clinic for evaluation of short stature
and poor school performance. Her past medical history
was positive for post term delivery (2 weeks delay) with
cesarean section and meconium aspiration, poor feeding,
severe high arced palate in infancy and a history of redden
face while crying, amblyopia at the age of 5 year old, poor
school performance and attention deficit (concentration
disturbance). She showed some abnormal repetitive verbal
and physical movements. Physical examination revealed
obesity with short neck, round face and brown spots on
her skin. Her height was 127 cm (below the third percent-
ile) and her weight was 50 kg (body mass index > 97th per-
centile). Mother’s height was 158 cm and father’s height
was 172 cm. Both hands appeared short, with markedly
short fourth and fifth metacarpals. Thyroid physical exam
showed a 15–20 gr, normal, not firm gland without any
palpable nodules. Laboratory data revealed normal serum
calcium (9.5 mg/dl), phosphorus (5.6 mg/dl) and intact
PTH (10 pg/ml). Serum TSH was 11 μU/ml. Her puberty
showed normal timing (menarche at 11 y and 6 months).
All laboratory tests are shown in Table 2.O phenotype
ical AHO phenotype Gsα levels (%) GNAS defects
Yes 50 + Gsα mutations
Yes 50 ± Gsα mutations
Yes 100 - Gsα mutations
Table 2 Clinical and laboratory findings of the patient
Variable Patient Normal range
Height (cm) 127 Below the 3th percentile
Weight (kg) 50 Above 97th percentile
Calcium (mg/dl) 9.5 8.5-10.5
Phosphate (mg/dl) 5.6 3.6-5.8
PTH (pg/ml) 10 10-62
TSH (μu/ml) 11 0.5-4
Anti-TPO Ab Negative <15
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fourth and fifth metacarps (Figure 1). Bone age was com-
patible with her age. Electromyography (EMG) and Nerve
conduction velocity (NCV) tests of four limbs were nor-
mal. Echocardiography showed an ejection fraction of
60%, other cardiac components were normal.
Karyotype analysis on peripheral lymphocytes was 46, XX
as a normal female chromosomal pattern with no chromo-
somal defect. We analyzed the 13 GNAS exons encoding
Gsα in genomic DNA and no mutations or alternations
could be identified. Gsα mRNA level, measured by qRt-
PCR using primers at exons 2 an 11, showed that the levelFigure 1 Left hand x-ray of case. Short 4th & 5th metacarpal.was not different from the controls. The subject and her
family gave informed consent to the study.
Neuropsychiatric findings
She had a febrile seizure at 1.5 years old and in early child-
hood recurrent generalized Tonic-clonic seizures with Ab-
normal EEG (frequent paroxysmal dysrhythmia) which
treated up to now with provision of neurologist. Stereo-
typed and repetitive motor mannerisms (hand flapping)
were present during infancy and early childhood as parents
registered. Severe impairment in social interactions as fail-
ure to develop age-appropriate peer relationship and severe
communication problems with family members especially
with mother are present. Beside, the patient had ritualistic
behaviors and compulsions (washing and repeating) which
significantly impaired her functioning and proposed co-
morbid obsessive-compulsive disorder. Academic failure
was present from elementary school stage and total intel-
lectual score using Wechsler intelligence scale was 68 and
suggests mild mental retardation. Episodes of binge eating
behavior present and patient was obviously obese. Mag-
netic Resonance Imaging (MRI) revealed bilateral ventri-
cles enlargement due to Cavum Septum Pellucidum.
Discussion
In this report, we present a patient with short stature and
poor school performance, with elevated TSH level diag-
nosed as hypothyroidism. The patient had normal calcium
and phosphate levels with no resistance to PTH hormone,
which did not lead to suspicion of PHP-Ia or Ib. We found
a short stature male in father’s family (his uncle) and a
short stature member (grandfather) in mother’s family;
however we have report of AHO phenotype in 2 cousins
of her, which suggest the paternally inherited pattern of
the disease.
These data and her laboratorial profile were compatible
with PPHP [7,19]. The patient had normal serum concen-
trations of calcium and phosphate for his age, and just his
elevated levels of TSH and his mother’s background was
compatible with the diagnosis of PHP-Ia [17]. Mariana
Tenorio Antunes Reis et al. [20] have also reported an in-
fant boy with AHO phenotype, normal calcium and phos-
phate levels, whose mother was diagnosed as PHP-Ia. The
functional analysis of GNAS exons showed a novel hetero-
zygous missense mutation in exon 5 of GNAS. They sug-
gest that AHO phenotype and normocalcemia does not
always mean PPHP, especially when the allele is maternally
inherited.
To investigate this possibility, the GNAS coding region
of patient was studied. There was no typical mutation in
GNAS coding region and the Gsα mRNA level did not ap-
pear to be deminished, which is compatible with Gsα pat-
tern in PHP-Ic [9]. It should be noted that our qRT-PCR
analysis of Gs-alpha mRNA was performed by generating
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through 11. Thus, given that certain other GNAS tran-
scripts share this region, the level of Gs-alpha mRNA de-
termined in our experiments may not entirely reflect the
expression of Gs-alpha transcript in case of any signficant
changes being observed in the level of expression. Sussane
Thiele et al. described 5 patients diagnosed as PHP-Ic in
whom they found TSH and PTH resistance, with normal
Gsα activity and inherited maternal inactivating mutations
in GNAS exons [21]. Linglart et al. [22] in a study on
genotype, phenotype relationship on the maternal trans-
mission of the hormonal resistance did not observe any
relationship between the erythrocyte Gsα activity and the
phenotype which may justify our findings in this patient.
This patient has high TSH and low anti TPO level which
leads to hypothyroidism. Joaquin Lado-Abeal et al. [23] re-
ported a family with congenital hypothyroidism due to
maternal inherited loss-of-function mutation of TSH re-
ceptor and AHO phenotype in two children of family due
to a paternal inherited mutation of GNAS,G alpha protein
subunit. This study suggests that our subject may have the
same inheritance pattern which leads to TSH resistance
and AHO phenotype, although we do not have enough
evidence to prove this hypothesis. Also studies have shown
that Gsα has a tissue specific manner, as YU S et al.
showed a mild PTH resistance despite normal TSH and
thyroid hormone levels in a mice because of imprinted
gene in renal tubules but not in other tissues [24]. A justi-
fication for some unusual and discordant findings in PHP
patients which has been confirmed by other studies re-
cently [25,26] may explain the hormonal resistance pattern
in this case.
These unusual findings make a difficulty in net diagnosis
for this case. This patient did not have PTH resistance
which cannot be classified as type Ia or Ib and at the same
time GNAS mutation was negative. Izraeli et al. also re-
ported a new variant of the syndrome, affecting 5 individ-
uals in a 3 generation family with AHO, normal Gs
activity and hypothyroidism [27]. Giovanna Mantovani
and colleges in a study on 40 patients have detected an ab-
sence of mutations in Gsα-coding GNAS exons although
they had the presence of PTH resistance [12]. Due to Gsα
inheritance pattern, it is suggested that PHP-Ia results
from a heterozygous inactivating mutation at GNAS
inherited from maternal allele while PPHP is inherited by
paternal alleles [7]. In this case the paternally inheritance
pattern, with normal Gsα activity and resistance to TSH
hormone make a discordance to categorize this patient
as PHP-Ia, Ic or PPHP. Although we did not do genome
sequencing to identify specific GNAS mutations in this
patient, Linglart et al. suggest that western blot could be
used to assess Gsα protein expression. They have report
three patients with PHP-Ia phenotype without any GNAS
mutations that hypothesize that normal Gsα proteinexpression and the absence of a mutation in the coding re-
gions makes the presence of a GNAS1 molecular defect
unlikely [22]. Davids et al. proposed that an alternative eti-
ology for PPHP is the deletion of STK25, inhibiting G pro-
tein signaling by a mechanism different from mutation of
the Gsα gene which may account for the PPHP condition
in the small group of patients with normal Gsα who still
experience the AHO phenotype [28]. Also, due to normal
karytoype in this patient, bracydactyly-mental retardation
syndrome with deletion in chromose 2 is not considered.
This deletion (MIM #600430) is often reffered to as Al-
bright hereditary osteodystrophy-like syndrome. These
patients with distal 2q deletions present with mild to
moderate intellectual disabilities, hypotonia, obesity,
short stature, and brachydactyly with short phalanges|(es-
pecially the third to fifth phalanges[brachydactyly type E],
as seen in patients with Albright syndrome [29]. No dys-
morphic features including thin, highly arched eyebrows,
prominent forehead, depressed nasal bridge, hypoplastic
alae nasi, prominent nasal septum, thin upper lip, and ear
anomalies (which are part of brachydactyly-mental retard-
ation syndrome) were not seen in our patient.
However the normal laboratory tests in our case, decline
the diagnosis of PHP-Ia. Analysis of PHP-Ia and PPHP
cases shows that individuals with isolated AHO and normal
Gsα activity exists [22]. So identifying of such individuals
may be useful to discover different genetic patterns in pseu-
dohypoparathyroidism and pseudopseudohypoparathyr-
oidism. Regarding to the reports by Nanclares et al. [5]
Mantovani et al. [12] and Sussane Thiele et al. [21], these
findings strengthen the need of new classifications of
GNAS related disorders due to this discordance reported
in this case and other similar cases described before.
The neuropsychiatric findings in our subject were com-
patible with Asperger syndrome diagnosis. Asperger syn-
drome is characterized by impairment in social interactions
and restrictive-repetitive pattern of behaviors and interest.
The syndrome belongs of Pervasive Developmental Disor-
ders (PDD) or Autism spectrum disorders [30]. The afore-
mentioned case with multiple medical complications had
prominent neuropsychiatric manifestations such as; gener-
alized Tonic-clonic seizures with Abnormal EEG, Stereo-
typed and repetitive motor mannerisms, severe impairment
in social interactions, severe communication problems with
family members, ritualistic behaviors and compulsions
(washing and repeating), mild mental retardation. Warwick
et al. [31] describes a case of a 23 years old man with
obsessive-compulsive behavior and agitation, temporal lobe
epilepsy (multiple generalized tonic-colonic seizures), some
developmental delay, and markedly impaired social interac-
tions toward family and at work with stereotyped and re-
petitive movements. He was diagnosed and treated as
Asperger syndrome, that his symptoms are compatible with
neuropsychiatric findings in our subject. In addition, the
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ger syndrome manifestations has not been reported to now
as we searched.
It will be important to identify patients in whom PHP
(or PPHP subtype) is caused by novel GNAS findings or
unusual clinical findings, as careful investigations of these
findings will likely further our knowledge of this complex
and this unique disorder. The most important point is that
this case presented with unusual neurologic findings
which has not been reported up to now.
Conclusion
According to our findings this patient could not be catego-
rized in any of PHP subgroups. Identifying of such individ-
uals may be useful to discover different genetic patterns in
pseudohypoparathyroidism and pseudopseudohypoparathyr-
oidism. It is important to identify patients in whom PHP is
caused by novel GNAS mutations, as careful investigations
of these findings will likely further our knowledge of this
complex and this unique disorder. In addition this case pre-
sented with unusual neuropsychiatric findings which has not
been reported up to now.
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